Utilizing a lung cancer mouse model with an intranasal administration of AD‐Cre‐induced KRAS G12D mutation, we assessed the alterations in IFGRNS scores during the tumour's growth phase, employing single‐cell sequencing to delineate the changes within the tumour and its microenvironment across distinct cell types. This evidence concerns the gene KRAS and neoplasm.